Douglas E Williams
EVP & President, R&D at Sana Biotechnology, Inc. (SANA) since April 2023
Douglas E Williams has filed 20 insider reports with the SEC since January 2021, as director at Camp4 Therapeutics Corp (CAMP), director at Climb Bio, Inc. (CLYM) and EVP & President and R&D at Sana Biotechnology, Inc. (SANA) and at 2 more companies. Douglas E Williams made no open-market purchases or sales in the last 12 months. The latest filing, on June 12, 2026, reports grant or award at Camp4 Therapeutics Corp (CAMP).
- Filings
- 20
- Companies
- 5
- Bought on market
- None
- Sold on market
- $30.7K
Companies where Douglas E Williams is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince March 2025 | $3.79 | Jun 12, 2026 | |||||
| Directorsince November 2024 | $9.19 | Jun 8, 2026 | |||||
| EVP & President, R&Dsince April 2023 | $1.59 | Mar 8, 2024 | |||||
| Officer, Director | 7,655 | $30.7K | Mar 30, 2023 | ||||
| Directorsince April 2021 | Apr 7, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 10, 2026CAMPSEC Form 4 filed by Director Williams Douglas EForm 4Grant or award
- Jun 5, 2026CLYMSEC Form 4 filed by Director Williams Douglas EForm 4Grant or award
- Jun 4, 2025CLYMSEC Form 4 filed by Director Williams Douglas EForm 4Grant or award
- Mar 31, 2025CLYMSEC Form 4 filed by Director Williams Douglas EForm 4Grant or award
- Mar 17, 2025CAMPSEC Form 4 filed by Director Williams Douglas EForm 4Grant or award
- Mar 17, 2025CAMPDouglas E Williams became an insiderForm 3New insider
- Nov 11, 2024CLYMSEC Form 4 filed by Director Williams Douglas EForm 4Grant or award
- Nov 8, 2024CLYMDouglas E Williams became an insiderForm 3New insider
- Mar 7, 2024SANASEC Form 4 filed by Williams Douglas EForm 4Grant or award
- Nov 2, 2023SANASEC Form 4 filed by Williams Douglas EForm 4Grant or award
- Apr 10, 2023SANASEC Form 4 filed by Williams Douglas EForm 4Grant or award
- Apr 10, 2023SANADouglas E Williams became an insiderForm 3New insider
- Mar 28, 2023-$7,500CDAKSEC Form 4 filed by Williams Douglas EForm 4Open-market sale
- Feb 17, 2023-$20.3KCDAKSEC Form 4: Williams Douglas E converted options into 45,938 shares and sold $20,288 worth of shares (14,793 units at $1.37), increasing direct ownership by 171% to 49,322 units (withholding tax)Form 4Exercise or conversion of a derivativeOpen-market sale
- Jan 24, 2023CDAKSEC Form 4 filed by Williams Douglas EForm 4Grant or award
- Jan 20, 2023-$2,918CDAKSEC Form 4: Williams Douglas E converted options into 13,667 shares and sold $2,918 worth of shares (5,075 units at $0.57), increasing direct ownership by 90% to 18,177 units (for tax liability)Form 4Exercise or conversion of a derivativeOpen-market sale
- Feb 16, 2022CDAKSEC Form 4 filed by Williams Douglas EForm 4Grant or award
- Jan 19, 2022CDAKSEC Form 4 filed by Williams Douglas EForm 4Grant or award
- Apr 6, 2021PANASEC Form 3 filed by E Douglas WilliamsForm 3New insider
- Jan 22, 2021CDAKSEC Form 4 filed by E Douglas WilliamsForm 4Grant or award
Compare Douglas E Williams with
- Douglas E Williams vs Stephen Basil Thomas1 shared
- Douglas E Williams vs Kelly Gold1 shared
- Douglas E Williams vs Andrew J. Schwab1 shared
- Douglas E Williams vs Dhavalkumar Dhirajlal Patel1 shared
- Douglas E Williams vs Daniel Tardiff1 shared
- Douglas E Williams vs Richard A Young1 shared
Other insiders at the same companies
- Ra Capital Management, L.P.CLYM
- Stephen Basil ThomasCLYM
- Kelly GoldCAMP
- Andrew J. SchwabCAMP
- Dhavalkumar Dhirajlal PatelSANA
- Daniel TardiffCAMP
- 5AM Partners VI, LLCCAMP
- Richard A YoungCAMP
- Yuri MaricichCAMP
- Josh Mandel-BrehmCAMP
- Hans Edgar BishopSANA
- Breanna Maurine CelebiCLYM
- Aoife BrennanCLYM
- Steven H HoltzmanCAMP
- Murray StewartCAMP
- Amir NashatCAMP
Questions about Douglas E Williams
- What is Douglas E Williams's role at Sana Biotechnology, Inc.?
- Douglas E Williams reports to the SEC as EVP & President and R&D at Sana Biotechnology, Inc. (SANA), according to the latest filing on March 8, 2024. Douglas E Williams has also filed as director at Camp4 Therapeutics Corp (CAMP), director at Climb Bio, Inc. (CLYM), officer and director at Codiak BioSciences, Inc. (CDAK) and director at Panacea Acquisition Corp. II (PANA).
- How many shares does Douglas E Williams own?
- After the latest filing that states it, Douglas E Williams directly owned 7,655 shares of Codiak BioSciences, Inc. (CDAK). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Douglas E Williams bought or sold stock recently?
- The most recent open-market sale was on March 28, 2023: sold 41,667 shares of Codiak BioSciences, Inc. (CDAK) for $7,500 at an average of $0.18.
- How do I get alerts when Douglas E Williams files?
- Follow Douglas E Williams on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Douglas E Williams (SEC CIK 0001184847). Totals count each trade once, skipping amendments whose original is on file, from Jan 26, 2021 on. View on SEC EDGAR · Get this as JSON